MNKD
MannKind Corporation
MNKD's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over MNKD overall, supported by lower modeled downside and stronger fundamentals.
MNKD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Weak |
MNKD's revenue is currently strong, but its profitability, cash flow and balance sheet are weak.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MNKD PE Valuation
MNKD has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 178x next year's earnings.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MNKD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
MNKD has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MNKD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.02 | — |
| Q3 2026 | -$0.23 | -330% |
| Q2 2026 | -$0.13 | -218% |
| Q1 2026 | -$0.07 | -170% |
| Q4 2025 | $0.02 | -80% |
| Q3 2025 | $0.10 | +25% |
| Q2 2025 | $0.11 | +120% |
| Q1 2025 | $0.10 | +150% |
| Q4 2024 | $0.10 | +$0.14 |
MNKD has swung to a loss: it lost $0.23 per share over the past year, after a profit the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over MNKD on earnings quality, reporting a profit while its opponent remains loss making.
MNKD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $101.9M | +24% |
| Q2 2026 | $109.4M | +43% |
| Q1 2026 | $90.2M | +15% |
| Q4 2025 | $112M | +46% |
| Q3 2025 | $82.1M | +17% |
| Q2 2025 | $76.5M | +5.7% |
| Q1 2025 | $78.4M | +18% |
| Q4 2024 | $76.8M | +31% |
MNKD has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.1% | -25 points |
| Q2 2026 | -0.3% | -7.2 points |
| Q1 2026 | -1.9% | -30 points |
| Q4 2025 | -6.9% | -41 points |
| Q3 2025 | 23% | +4.8 points |
| Q2 2025 | 6.9% | -16 points |
| Q1 2025 | 28% | +3.2 points |
| Q4 2024 | 35% | +21 points |
MNKD's operating margin was −2.1% last quarter, down 25 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over MNKD on profitability, with a higher operating margin.
MNKD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$37.8M | -268% |
| Q2 2026 | -$23.5M | -399% |
| Q1 2026 | -$7.2M | -$538K |
| Q4 2025 | -$10M | -150% |
| Q3 2025 | $22.5M | +184% |
| Q2 2025 | $7.8M | +810% |
| Q1 2025 | -$6.7M | -256% |
| Q4 2024 | $19.7M | +25% |
MNKD has burned cash in most quarters: −$78M over the past year, against $43M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over MNKD on cash generation, producing positive trailing cash flow while its opponent burns cash.
MNKD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +11M shares |
| 1 year | +2.7% | +8.5M shares |
| 3 years | -1.1% | -3.6M shares |
| 5 years | +28% | +70.3M shares |
| Available history | +55% | +113M shares |
MNKD has 320M diluted shares, up 2.7% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over MNKD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
MNKD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 19.7x | High |
| Q2 2026 | 8.9x | High |
| Q1 2026 | 8.5x | High |
| Q4 2025 | 5.5x | High |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
MNKD's net debt is about 20 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over MNKD on leverage, with a lower net debt burden relative to earnings.
MNKD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.4 | Neutral |
| Stochastic | 63.7 | Neutral |
MNKD's weekly RSI is 55 (neutral) and its Stochastic is 64 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
MNKD PE vs Healthcare Sector
| Metric | MNKD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
MNKD has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
MNKD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 18% above |
| 20 week MA | $3.82 | 8.9% above |
| 50 week MA | $4.00 | 4% above |
| 100 week MA | $4.48 | 7.1% below |
| 200 week MA | $4.62 | 10% below |
MNKD has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 10% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over MNKD on trend strength, trading above more of its moving averages.
MNKD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.37 | $3.42 | +150% |
| 2021 | $3.42 | $4.46 | +30% |
| 2022 | $4.46 | $5.09 | +14% |
| 2023 | $5.09 | $3.64 | -28% |
| 2024 | $3.64 | $6.82 | +87% |
| 2025 | $6.82 | $5.79 | -15% |
| 2026 YTD | $5.79 | $4.16 | -28% |
MNKD has finished higher in four of the last six years, two of them by more than 50%. It's down 28% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over MNKD on returns for 2026, with the stronger performance.